What is the recommended dosing for isotretinoin (13-cis-retinoic acid) in the treatment of acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Isotretinoin Dosing for Acne

Dosing Strategy Based on Acne Severity

For severe acne, start isotretinoin at 0.5 mg/kg/day for the first month, then increase to 1.0 mg/kg/day thereafter as tolerated, targeting a cumulative dose of 120-150 mg/kg to minimize relapse rates. 1, 2

Severe Acne Dosing Protocol

  • Initial dose: Begin at 0.5 mg/kg/day for the first month 1
  • Maintenance dose: Increase to 1.0 mg/kg/day after month one as tolerated 1
  • Target cumulative dose: 120-150 mg/kg provides optimal balance between efficacy and relapse prevention 1
  • Treatment duration: Typically 15-20 weeks depending on cumulative dose target 2
  • Dose adjustments: Patients with very severe disease or extensive truncal involvement may require up to 2 mg/kg/day as tolerated 2

The evidence strongly supports this approach because higher daily doses (1.0 mg/kg/day vs 0.5 mg/kg/day) and cumulative doses (≥120 mg/kg vs <120 mg/kg) significantly reduce relapse rates and need for retreatment, even though initial clearing rates are similar. 1 The therapeutic benefit appears to plateau beyond 150 mg/kg cumulative dose. 1

Moderate Acne Dosing Protocol

For treatment-resistant or quick-relapsing moderate acne, use low-dose isotretinoin at 0.25-0.4 mg/kg/day (typically 20 mg/day), which provides comparable efficacy to conventional dosing with fewer side effects and equal relapse rates. 1

  • Recommended dose: 0.25-0.4 mg/kg/day (approximately 20 mg/day for most patients) 1, 3
  • Treatment duration: 6 months minimum 3
  • Efficacy: 90-95% of patients achieve good results 3, 4
  • Relapse rates: 4-6% over 4-6 year follow-up, comparable to conventional dosing for moderate acne 3, 4
  • Side effect profile: Significantly reduced compared to higher doses while maintaining efficacy 1, 3

Unlike severe acne where higher cumulative doses reduce relapse, moderate acne shows equal relapse rates between low-dose and conventional dosing regimens. 1 This makes low-dose therapy the preferred approach for this population.

Critical Administration Requirements

Isotretinoin must be taken with meals in two divided daily doses to ensure adequate absorption, as taking it without food significantly decreases bioavailability. 1, 2

  • Take with food to optimize absorption due to high lipophilicity 1, 2
  • Administer in two divided doses daily 2
  • One lidose formulation can be taken on empty stomach but standard formulations require food 1
  • Once-daily dosing has not been established as safe and is not recommended 2

Dosing Approaches to Avoid

Intermittent dosing is not recommended as it is associated with significantly higher relapse rates compared to continuous daily dosing. 1

Special Considerations for Extremely Severe Cases

  • For acne fulminans or extremely severe presentations, consider starting at even lower doses than 0.5 mg/kg/day 1
  • Concomitant oral corticosteroids (prednisone 0.5-1 mg/kg/day) may be needed to prevent isotretinoin-induced flares 1
  • Slow taper of steroids over several months while continuing isotretinoin 1

Retreatment Protocol

  • If total nodule count reduces by >70% before completing 15-20 weeks, isotretinoin may be discontinued 2
  • Wait at least 2 months off therapy before considering a second course 2
  • Second courses use the same dosing strategy as initial treatment 1, 2
  • Long-term continuous use, even at low doses, is not recommended due to unknown effects on bone density 2

Common Pitfall

The most critical error is failing to verify that patients take isotretinoin with food. Before increasing doses due to perceived treatment failure, always confirm dietary compliance, as absorption without food is significantly impaired. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Low-dose isotretinoin in the treatment of acne vulgaris.

Journal of the American Academy of Dermatology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.